Sanofi taps se­r­i­al biotech in­vestor, en­tre­pre­neur as R&D chief — while pro­mot­ing busi­ness op­er­a­tions, dig­i­tal lead­ers

Six months af­ter John Reed made a sur­prise ex­it, Sanofi has ze­roed in on a new head of R&D, re­cruit­ing a biotech builder out of SV Health In­vestors.

Houman Ashrafi­an, cur­rent­ly a man­ag­ing part­ner at SV, will start his new role in Sep­tem­ber, join­ing sev­er­al new mem­bers of Sanofi’s ex­ec­u­tive com­mit­tee. Em­manuel Frene­hard, now glob­al head of dig­i­tal, has been pro­mot­ed to chief dig­i­tal of­fi­cer. Bri­an Foard will take over the spe­cial­ty care glob­al busi­ness unit on an in­ter­im ba­sis, as Bill Si­bold leaves the com­pa­ny to pur­sue a new op­por­tu­ni­ty.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER